CB Insights reported record funding for global healthcare and digital health, among other milestones during the third quarter. Global healthcare investments to private companies hit a new quarterly record of $21.8 billion in the third quarter of this year, with a total of 1,539 equity investments in the three-month period growing 18% from the previous […]
About two-fifths of the startups in CB Insights’ second annual Digital Health 150 list are engaged in telehealth, a high-demand area amid the COVID-19 pandemic. That is one of the big takeaways from the list of 150 promising digital health startups that CB Insights released today. CB Insights’ research team picked the 150 startups after […]
Startups pioneering less-invasive technologies to treat common eye diseases are changing the outlook for both patients and the industry. A new study by CB Insights revealed that investors have been pouring money into smaller companies in 2017 and 2018, with some FDA approvals to begin marketing their technologies and treatments. These firms are eyeing conditions […]
Investment spending in the drug delivery sector has dropped significantly for the third quarter, but is staying ahead of last years numbers for the first through third quarters, according to a new report. Venture capital investments fell a significant 61.8% to $29.6 million during the three months ended September 30, though deal volume stayed the […]
Investors spent less money on fewer deals in the medical device sector during the third quarter and so far this year, bucking the overall growth trend for venture capital-backed firms, according to a new report. Venture capital investment fell -19.7% to $772.7 million during the three months ended Sept. 30, with deal volume down -20.3% […]
Venture Capital funding in the healthcare sector during the third quarter of 2017 stayed mostly in line with the previous quarter while digital health deals saw a significant drop, according to a PricewaterhouseCoopers and CB Insights MoneyTree report. VC funding during the third quarter of 2017 was directly in line with the previous quarter, but […]
The surge of medical device IPOs during the 1st quarter wasn’t mirrored by venture capital investment, although medtech firms tied for the most number of healthcare deals during the quarter, according to CB Insights.
Medical device and biotech VC transactions each accounted for 27% of healthcare deals during the quarter, according to the data consulting firm.
Medical device companies pulled in more than $255 million from investors in 29 deals during January, according to data provided to MassDevice.com by CB Insights Inc.
The deals ranged widely in size, from a $25,000 seed round investment for Elyira, Ohio-based Guided Interventions and its passive coronary artery blockage sensing technology to a $43 million Series D round for EndoChoice and its endoscopes.